Business

Grant of US patent

Grant of US patent.

articleProvexis PlcMarch 21, 20073/company/provexis-plc/news/grant-of-us-patent-2
Grant of US patent

About this update from Provexis Plc

[{"type":"text","content":"\n Provexis PLC\n21 March 2007\n\n21 March 2007\n\n PROVEXIS plc\n ('Provexis' or the 'Company')\n\n GRANT OF US PATENT FOR INFLAMMATORY BOWEL DISEASE TECHNOLOGY\n\nProvexis plc, the nutraceutical company that develops scientifically-proven\nfunctional and medical foods, announces that the US Patent Office has granted a\npatent for its plantain-based extract for the treatment of Inflammatory Bowel\nDisease ('IBD').\n\nProvexis has been developing the plantain-based extract in conjunction with its\npartner, the University of Liverpool, with the aim of extending periods of\nremission in Crohn's Disease patients. A prototype product is currently\nundergoing final testing, and the Company will shortly be applying for\nauthorisation to commence a large-scale one-year human trial later in 2007.\n\n\nStephen Moon, CEO commented:\n\n'We are pleased that the patent for our plantain technology has been granted in\nthe world's largest market. Preparations for the human trial are now well\nadvanced and we believe this important element of our pipeline will deliver\nsignificant shareholder value in the future.'\n\n -ends-\n\n\nFor further information please contact:\n\nStephen Moon, CEO\nProvexis plc Tel: 020 8392 6631\n\nTom Griffiths/Richard Johnson\nArbuthnot Securities Tel: 020 7012 2000\n\n\nNotes:\n\nCrohn's Disease is a type of IBD affecting 1 in 600 people in the developed\nworld. Current treatments are expensive, have limited efficacy and can also have\nsignificant side effects. Given the debilitating nature of the disease, an\nefficacious and cost effective supplement specifically aimed at the maintenance\nof remission should be attractive to the medical profession and Crohn's Disease\nsufferers. The fruit of the plantain, which is similar to the banana, contains a\ntype of soluble fibre with bioactive properties.\n\n\n\n\n\n\n This information is provided by RNS\n The company news service from the London Stock Exchange\n \n ","length":2313,"tagName":"div"}]

More updates from Provexis Plc